Yahoo
NasdaqGM - Delayed Quote USD

SL Science Holding Limited (SLBT)

0.9375 +0.0374 (+4.16%)
At close: November 6 at 4:00:00 PM EST
Chart Range Bar
Loading chart for SLBT
  • Previous Close 0.9001
  • Open 0.9024
  • Bid 3.1600 x 800
  • Ask 4.0000 x 100
  • Day's Range 0.9001 - 1.0166
  • 52 Week Range 0.7400 - 14.5000
  • Volume 53,649
  • Avg. Volume 65,356
  • Market Cap (intraday) 525.712M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est --
  • Moby Rating Neutral

SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its name to SL Science Holding Limited in June 2026. The company is based in Taipei, Taiwan.

www.sl-bio.com

14

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SLBT
91.11%
S&P 500 (^GSPC)
7.76%

1-Year Return

SLBT
90.98%
S&P 500 (^GSPC)
9.77%

3-Year Return

SLBT
90.70%
S&P 500 (^GSPC)
68.96%

5-Year Return

SLBT
90.70%
S&P 500 (^GSPC)
57.04%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -72.46%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    3.27M

  • Net Income Avi to Common (ttm)

    -2.37M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.37M

  • Total Debt/Equity (mrq)

    6.46%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: